Richard E Lowenthal

CIK 1378550 · PRESIDENT AND CEO · last filed 2026-01-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$128.70M

Companies

2

Total Filings

32

Lifetime Open-Market Net

-$23.82M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPRY PRESIDENT AND CEO 13,186,389 $9.76 $128.70M -$23.82M 31 2026-01-05
CADENCE PHARMACEUTICALS INC (CADX) Delisted VP $0 1 2007-03-26

Recent Filings · Page 3 of 4

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-04-22 SPRY Exer (M) +188,491 $200.0K EDGAR
2024-04-17 SPRY Sell (S) −100,000 -$928.0K EDGAR
2024-04-10 SPRY Sell (S) −100,000 -$927.7K EDGAR
2024-03-26 SPRY Sell (S) −97,610 -$890.3K EDGAR
2024-03-21 SPRY Sell (S) −2,390 -$21.6K EDGAR
2024-03-15 SPRY Sell (S) −100,000 -$913.7K EDGAR
2024-03-01 SPRY Sell (S) −3,782 -$34.1K EDGAR
2024-02-28 SPRY Sell (S) −99,478 -$897.4K EDGAR
2024-01-04 SPRY Mixed $0 EDGAR
2023-01-05 SPRY Grant (A) $0 EDGAR
Showing 2130 of 32
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.